Efficacy and Safety of Abiraterone Acetate in Elderly (≥75 Years) Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Metastatic castration-resistant prostate cancer primarily affects elderly men. In this post hoc analysis we investigated the safety and efficacy of abiraterone acetate in elderly (≥75 years) and younger (<75 years) patient subgroups at the prespecified interim analysis (55% of total over...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Urol
Glavni autori: Smith, Matthew R., Rathkopf, Dana E., Mulders, Peter. F.A., Carles, Joan, Van Poppel, Hendrik, Li, Jinhui, Kheoh, Thian, Griffin, Thomas W., Molina, Arturo, Ryan, Charles J.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129174/
https://ncbi.nlm.nih.gov/pubmed/26151676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2015.07.004
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items